XML 43 R37.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Reporting (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Segment Data and Reconciliations of Segment Data to Consolidated Financial Statements and Non-GAAP Measures | The following is segment data for the three and six months ended June 30, 2025 and 2024, and reconciliations of segment data to the condensed consolidated financial statements:
|  | For the Three Months Ended June 30, 2025 |
(In thousands) |  | Surfactants |  |  | Polymers |  |  | Specialty Products |  |  | Total |
Net Sales |  | $ | 411,456 |  |  | $ | 162,751 |  |  | $ | 20,482 |  |  | $ | 594,689 |
Cost of Sales (1) |  |  | 370,660 |  |  |  | 138,124 |  |  |  | 14,293 |  |  |  | 523,077 |
Operating Expenses (2) |  |  | 27,429 |  |  |  | 7,468 |  |  |  | 931 |  |  |  | 35,828 |
Operating Income |  | $ | 13,367 |  |  | $ | 17,159 |  |  | $ | 5,258 |  |  | $ | 35,784 |
Unallocated Corporate Expenses (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (17,819 | )
Consolidated Operating Income |  |  |  |  |  |  |  |  |  |  | $ | 17,965 |
Segment Capital Expenditures |  | $ | 19,675 |  |  | $ | 4,581 |  |  | $ | 866 |  |  | $ | 25,122 |
Unallocated Capital Expenditures (4) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 476 |
Consolidated Capital Expenditures |  |  |  |  |  |  |  |  |  |  | $ | 25,598 |
Segment Depreciation and Amortization |  | $ | 21,137 |  |  | $ | 8,352 |  |  | $ | 1,472 |  |  | $ | 30,961 |
Unallocated Depreciation and Amortization (5) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 328 |
Consolidated Depreciation and Amortization |  |  |  |  |  |  |  |  |  |  | $ | 31,289 |
|  | For the Six Months Ended June 30, 2025 |
(In thousands) |  | Surfactants |  |  | Polymers |  |  | Specialty Products |  |  | Total |
Net Sales |  | $ | 841,793 |  |  | $ | 308,867 |  |  | $ | 37,284 |  |  | $ | 1,187,944 |
Cost of Sales (1) |  |  | 747,326 |  |  |  | 269,020 |  |  |  | 24,690 |  |  |  | 1,041,036 |
Operating Expenses (2) |  |  | 52,170 |  |  |  | 14,670 |  |  |  | 1,828 |  |  |  | 68,668 |
Operating Income |  | $ | 42,297 |  |  | $ | 25,177 |  |  | $ | 10,766 |  |  | $ | 78,240 |
Unallocated Corporate Expenses (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (31,987 | )
Consolidated Operating Income |  |  |  |  |  |  |  |  |  |  | $ | 46,253 |
Segment Capital Expenditures |  | $ | 43,679 |  |  | $ | 11,652 |  |  | $ | 1,946 |  |  | $ | 57,277 |
Unallocated Capital Expenditures (4) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,069 |
Consolidated Capital Expenditures |  |  |  |  |  |  |  |  |  |  | $ | 58,346 |
Segment Depreciation and Amortization |  | $ | 40,567 |  |  | $ | 16,413 |  |  | $ | 2,961 |  |  | $ | 59,941 |
Unallocated Depreciation and Amortization (5) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 618 |
Consolidated Depreciation and Amortization |  |  |  |  |  |  |  |  |  |  | $ | 60,559 |
|  | For the Three Months Ended June 30, 2024 |
(In thousands) |  | Surfactants |  |  | Polymers |  |  | Specialty Products |  |  | Total |
Net Sales |  | $ | 379,795 |  |  | $ | 159,757 |  |  | $ | 16,853 |  |  | $ | 556,405 |
Cost of Sales (1) |  |  | 338,908 |  |  |  | 139,111 |  |  |  | 8,775 |  |  |  | 486,794 |
Operating Expenses (2) |  |  | 23,825 |  |  |  | 7,049 |  |  |  | 759 |  |  |  | 31,633 |
Operating Income |  | $ | 17,062 |  |  | $ | 13,597 |  |  | $ | 7,319 |  |  | $ | 37,978 |
Unallocated Corporate Expenses (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (19,311 | )
Consolidated Operating Income |  |  |  |  |  |  |  |  |  |  | $ | 18,667 |
Segment Capital Expenditures |  | $ | 26,036 |  |  | $ | 2,616 |  |  | $ | 1,058 |  |  | $ | 29,710 |
Unallocated Capital Expenditures (4) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Consolidated Capital Expenditures |  |  |  |  |  |  |  |  |  |  | $ | 29,710 |
Segment Depreciation and Amortization |  | $ | 17,863 |  |  | $ | 8,192 |  |  | $ | 1,497 |  |  | $ | 27,552 |
Unallocated Depreciation and Amortization (5) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 458 |
Consolidated Depreciation and Amortization |  |  |  |  |  |  |  |  |  |  | $ | 28,010 |
|  | For the Six Months Ended June 30, 2024 |
(In thousands) |  | Surfactants |  |  | Polymers |  |  | Specialty Products |  |  | Total |
Net Sales |  | $ | 770,615 |  |  | $ | 305,265 |  |  | $ | 31,943 |  |  | $ | 1,107,823 |
Cost of Sales (1) |  |  | 679,286 |  |  |  | 269,543 |  |  |  | 18,796 |  |  |  | 967,625 |
Operating Expenses (2) |  |  | 48,187 |  |  |  | 13,743 |  |  |  | 1,560 |  |  |  | 63,490 |
Operating Income |  | $ | 43,142 |  |  | $ | 21,979 |  |  | $ | 11,587 |  |  | $ | 76,708 |
Unallocated Corporate Expenses (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (37,872 | )
Consolidated Operating Income |  |  |  |  |  |  |  |  |  |  | $ | 38,836 |
Segment Capital Expenditures |  | $ | 52,620 |  |  | $ | 5,121 |  |  | $ | 2,126 |  |  | $ | 59,867 |
Unallocated Capital Expenditures (4) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Consolidated Capital Expenditures |  |  |  |  |  |  |  |  |  |  | $ | 59,867 |
Segment Depreciation and Amortization |  | $ | 35,529 |  |  | $ | 16,235 |  |  | $ | 2,974 |  |  | $ | 54,738 |
Unallocated Depreciation and Amortization (5) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 876 |
Consolidated Depreciation and Amortization |  |  |  |  |  |  |  |  |  |  | $ | 55,614 |
T he following is segment assets at June 30, 2025 and December 31, 2024, and reconciliations of segment assets to the condensed consolidated financial statements.
|  | As of June 30, 2025 |
(In thousands) |  | Surfactants |  |  | Polymers |  |  | Specialty Products |  |  | Total |
Segment Assets |  | $ | 1,654,136 |  |  | $ | 552,106 |  |  | $ | 81,600 |  |  | $ | 2,287,842 |
Unallocated Assets (6) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 128,288 |
Consolidated Assets |  |  |  |  |  |  |  |  |  |  | $ | 2,416,130 |
|  | As of December 31, 2024 |
(In thousands) |  | Surfactants |  |  | Polymers |  |  | Specialty Products |  |  | Total |
Segment Assets |  | $ | 1,578,689 |  |  | $ | 523,192 |  |  | $ | 70,898 |  |  | $ | 2,172,779 |
Unallocated Assets (6) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 131,869 |
Consolidated Assets |  |  |  |  |  |  |  |  |  |  | $ | 2,304,648 |
(1) Cost of sales is comprised of raw material costs (including freight and shipping/handling expenses to deliver the raw materials), manufacturing plant labor expenses and other manufacturing overhead expenses, such as utilities, maintenance, depreciation, etc., that can be allocated to reportable segments. (2) Operating expenses allocated to reportable segments are comprised of selling, administrative and research and development expenses. The CODM uses operating expenses in aggregate to analyze the performance of each reportable segment. (3) Unallocated corporate expenses are primarily comprised of corporate administrative expenses (e.g., corporate finance, legal, human resources, information technology and environmental remediation expenses), deferred compensation and business restructuring and assets impairment expenses that are not included in segment operating income and not used to evaluate segment performance. (4) Unallocated capital expenditures primarily include capital expenditures related to the Company’s Northfield, Illinois location. (5) Unallocated depreciation and amortization primarily includes depreciation related to the Company’s Northfield, Illinois location. (6) Unallocated assets primarily include assets in the Company’s Northfield, Illinois location.

X
- Definition Segment data and reconciliation of operating profit loss from segments to consolidated financial statements and non-gaap measures. + References No definition available. + Details
Name: | scl_SegmentDataAndReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedFinancialStatementsAndNonGaapMeasuresTableTextBlock
Namespace Prefix: | scl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration